Clinical trial
A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT00034905 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00034905 |
|---|---|
| Title | A Comparison of Seroquel vs. Risperidone in Schizophrenia |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | quetiapine fumarate vs risperidone |
| Start date | Jul 1, 2001 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | May 3, 2002 |
| Last update posted | Jan 4, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: